Literature DB >> 19725049

Epac1-induced cellular proliferation in prostate cancer cells is mediated by B-Raf/ERK and mTOR signaling cascades.

Uma Kant Misra1, Salvatore Vincent Pizzo.   

Abstract

cAMP-dependent, PKA-independent effects on cell proliferation are mediated by cAMP binding to EPAC and activation of Rap signaling. In this report, we employed the analogue 8-CPT-2-O-Me-cAMP to study binding to EPAC and subsequent activation of B-Raf/ERK and mTOR signaling in human cancer cells. This compound significantly stimulated DNA synthesis, protein synthesis, and cellular proliferation of human 1-LN prostate cancer cells. By study of phosphorylation-dependent activation, we demonstrate that EPAC-mediated cellular effects require activation of the B-Raf/ERK and mTOR signaling cascades. RNAi directed against EPAC gene expression as well as inhibitors of ERK, PI 3-kinase, and mTOR were employed to further demonstrate the role of these pathways in regulating prostate cancer cell proliferation. These studies were then extended to several other human prostate cancer cell lines and melanoma cells with comparable results. We conclude that B-Raf/ERK and mTOR signaling play an essential role in cAMP-dependent, but PKA-independent, proliferation of cancer cells. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19725049      PMCID: PMC4354900          DOI: 10.1002/jcb.22333

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  48 in total

Review 1.  Rap1 GTPase: functions, regulation, and malignancy.

Authors:  Masakazu Hattori; Nagahiro Minato
Journal:  J Biochem       Date:  2003-10       Impact factor: 3.387

2.  Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner.

Authors:  Ariel F Castro; John F Rebhun; Geoffrey J Clark; Lawrence A Quilliam
Journal:  J Biol Chem       Date:  2003-07-03       Impact factor: 5.157

Review 3.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

4.  Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer.

Authors:  Hui Gao; Xuesong Ouyang; Whitney A Banach-Petrosky; William L Gerald; Michael M Shen; Cory Abate-Shen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-14       Impact factor: 11.205

Review 5.  Ras, PI(3)K and mTOR signalling controls tumour cell growth.

Authors:  Reuben J Shaw; Lewis C Cantley
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

6.  Coordinate regulation of forskolin-induced cellular proliferation in macrophages by protein kinase A/cAMP-response element-binding protein (CREB) and Epac1-Rap1 signaling: effects of silencing CREB gene expression on Akt activation.

Authors:  Uma K Misra; Salvatore V Pizzo
Journal:  J Biol Chem       Date:  2005-09-19       Impact factor: 5.157

7.  Prostaglandin E(2) induces breast cancer related aromatase promoters via activation of p38 and c-Jun NH(2)-terminal kinase in adipose fibroblasts.

Authors:  Dong Chen; Scott Reierstad; Zhihong Lin; Meiling Lu; Chris Brooks; Newton Li; Joy Innes; Serdar E Bulun
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

Review 8.  Targeting RSK: an overview of small molecule inhibitors.

Authors:  Tam Luong Nguyen
Journal:  Anticancer Agents Med Chem       Date:  2008-10       Impact factor: 2.505

9.  PGE(2) induces COX-2 expression in podocytes via the EP(4) receptor through a PKA-independent mechanism.

Authors:  Wissam H Faour; Kaede Gomi; Christopher R J Kennedy
Journal:  Cell Signal       Date:  2008-08-15       Impact factor: 4.315

10.  The cyclic AMP effector Epac integrates pro- and anti-fibrotic signals.

Authors:  Utako Yokoyama; Hemal H Patel; N Chin Lai; Nakon Aroonsakool; David M Roth; Paul A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-23       Impact factor: 11.205

View more
  35 in total

1.  Activated α2-macroglobulin binding to human prostate cancer cells triggers insulin-like responses.

Authors:  Uma Kant Misra; Salvatore Vincent Pizzo
Journal:  J Biol Chem       Date:  2015-02-26       Impact factor: 5.157

2.  Epac1 knockdown inhibits the proliferation of ovarian cancer cells by inactivating AKT/Cyclin D1/CDK4 pathway in vitro and in vivo.

Authors:  Meng Gao; Yanyan Ma; Robert C Bast; Yue Li; Lu Wan; Yanping Liu; Yingshuo Sun; Zhenghui Fang; Lining Zhang; Xiaoyan Wang; Zengtao Wei
Journal:  Med Oncol       Date:  2016-06-08       Impact factor: 3.064

Review 3.  The pharmacology of nociceptor priming.

Authors:  Ram Kandasamy; Theodore J Price
Journal:  Handb Exp Pharmacol       Date:  2015

Review 4.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

Authors:  William G Robichaux; Xiaodong Cheng
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

5.  Pharmacological inhibition and genetic knockdown of exchange protein directly activated by cAMP 1 reduce pancreatic cancer metastasis in vivo.

Authors:  Muayad Almahariq; Celia Chao; Fang C Mei; Mark R Hellmich; Igor Patrikeev; Massoud Motamedi; Xiaodong Cheng
Journal:  Mol Pharmacol       Date:  2014-11-10       Impact factor: 4.436

6.  Isoform-specific antagonists of exchange proteins directly activated by cAMP.

Authors:  Tamara Tsalkova; Fang C Mei; Sheng Li; Oleg G Chepurny; Colin A Leech; Tong Liu; George G Holz; Virgil L Woods; Xiaodong Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

7.  Type 10 soluble adenylyl cyclase is overexpressed in prostate carcinoma and controls proliferation of prostate cancer cells.

Authors:  Jan-Paul Flacke; Hanna Flacke; Avinash Appukuttan; Rein-Jüri Palisaar; Joachim Noldus; Brian D Robinson; H Peter Reusch; Jonathan H Zippin; Yury Ladilov
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

8.  A novel EPAC-specific inhibitor suppresses pancreatic cancer cell migration and invasion.

Authors:  Muayad Almahariq; Tamara Tsalkova; Fang C Mei; Haijun Chen; Jia Zhou; Sarita K Sastry; Frank Schwede; Xiaodong Cheng
Journal:  Mol Pharmacol       Date:  2012-10-11       Impact factor: 4.436

9.  RNAi screen indicates widespread biological function for human natural antisense transcripts.

Authors:  Mohammad Ali Faghihi; Jannet Kocerha; Farzaneh Modarresi; Pär G Engström; Alistair M Chalk; Shaun P Brothers; Eric Koesema; Georges St Laurent; Claes Wahlestedt
Journal:  PLoS One       Date:  2010-10-04       Impact factor: 3.240

10.  Balancing GRK2 and EPAC1 levels prevents and relieves chronic pain.

Authors:  Huijing Wang; Cobi J Heijnen; Cindy T J van Velthoven; Hanneke L D M Willemen; Yoshihiro Ishikawa; Xinna Zhang; Anil K Sood; Anne Vroon; Niels Eijkelkamp; Annemieke Kavelaars
Journal:  J Clin Invest       Date:  2013-11-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.